type cytokines (interleukin-2 [IL-2] and gamma interferon) and that of Th2-type cytokines (IL-4, IL-5, and IL-10) are mutually exclusive. In contrast, there have been reports of the existence of both Th1-and Th2-type responses, together with antibodies, in murine and human visceral leishmaniasis, with a dominance of Th1 with protective immunity (7, 14, (28) (29) (30) 40) The development of vaccines is the essential aim of studies on leishmaniasis. Extensive investigations in this field include human vaccine trials with killed promastigotes and immunization of mice with attenuated, killed, and crude parasite fractions, as well as purified and recombinant antigens and their DNA (11, 17, 31, 34, (53) (54) (55) 59 ). While there is still no effective form of immunoprophylaxis against this disease, the impressive recent advances in this area may soon result in the development of a safe and effective vaccine. The protocols used successfully with L. major and L. mexicana infection, however, have been reported to be unsuccessful against murine visceral leishmaniasis (24, 29, 39) . The problems in achieving immunization may be why there are few studies of vaccines against L. donovani (23, 44) . Recently, we showed that membrane antigens of L. donovani promastigotes (LAg), when entrapped in liposomes (LAg in liposomes), could induce very significant levels of protection against infection in both hamsters and BALB/c mice (3) . The extent of protection induced by these antigens in mice, however, varied depending on the charge of liposomes introduced as adjuvants such that positively charged liposomes induced maximum protection (87%) (3), followed by neutral (73%) (6) and negatively charged liposomes (59.4%) (5) . Identification of the key components of the complex antigen mixture (LAg) incorporated in the liposome preparations and determining their involvement in conferring protective immunity are essential for the design of future subunit-based vaccines against kala-azar. For this purpose, immunoblots of LAg and LAg in liposomes probed with infected sera and with sera from immunized BALB/c mice before and after infection were analyzed. Results show that, in addition to gp63, the major promastigote surface glycoprotein, 72-, 52-, 48-, 45-, 39-, and 20-kDa components of LAg are potent antigenic targets for the development of vaccine against L. donovani.
MATERIALS AND METHODS
Parasites and culture conditions. Promastigotes of L. donovani, strain AG83, were grown at 22°C in medium 199 (pH 7.4) supplemented with 10% heatinactivated fetal bovine serum, 2 mM L-glutamine, 100 U of penicillin G sodium, and 100 g of streptomycin sulfate per ml and subcultured in the same medium at an average density of 2 ϫ 10 6 cells/ml (6) . Preparation of Leishmania antigens. LAg were prepared from L. donovani promastigotes as described earlier (3) . Briefly, stationary-phase promastigotes, harvested after the third or fourth passage, were washed four times in cold 20 mM phosphate-buffered saline (PBS), pH 7.2, and resuspended at a concentration of 1.0 g of cell pellet in 50 ml of cold 5 mM Tris-HCl buffer, pH 7.6. The suspension was vortexed and centrifuged at 2,310 ϫ g for 10 min. The crude ghost membrane pellet thus obtained was resuspended in the same Tris buffer and sonicated in an ultrasonicator. The suspension was centrifuged at 5,190 ϫ g for 30 min, and the supernatant containing the leishmanial antigens was harvested and stored at Ϫ70°C until use. The amount of protein obtained from a 1.0-g cell pellet, as assayed by the method of Lowry et al. (35) , was approximately 16 mg.
Soluble leishmanial antigens (SLA) were also extracted from L. donovani promastigote membranes. The washed parasites were suspended in cold 5 mM Tris-HCl buffer (pH 7.6) containing 5 g of leupeptin/ml, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM iodoacetamide (lysis buffer) and were vortexed and centrifuged as described for LAg. The membrane pellet was resuspended in 10 ml of lysis buffer and sonicated as described above. The suspension thus obtained was solubilized with 1% (wt/vol) octyl-␤-D-glucopyranoside in the lysis buffer, with overnight incubation at 4°C, and was finally ultracentrifuged for 1 h at 100,000 ϫ g. The supernatant containing SLA was then dialyzed against 1 mM Tris-HCl buffer (pH 7.6) and stored at Ϫ70°C until use. The amount of protein obtained from a 1.0-g cell pellet was approximately 2 mg.
The 63-kDa membrane glycoprotein, gp63, was purified by monoclonal affinity binding from Nonidet P-40 extracts of Leishmania amazonensis promastigotes and was a kind gift from K. P. Chang.
Electroelution of gp63 from SDS-PAGE gels. The SLA from L. donovani promastigotes was subjected to sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis (SDS-10% PAGE), and the protein with a molecular mass of 63 kDa (gp63) was localized in gels, stained with Coomassie blue, and eluted by electrophoresis in running buffer (0.025 M Tris, 0.192 M glycine, 1% SDS) at 10 mA for 5 h. After elution, the protein was dialyzed, lyophilized, resuspended in PBS, and filtered through 0.22-m-pore-size membranes for further utilization in lymphocyte cultures (8) . The protein was quantified by Lowry's method (35) .
Entrapment of leishmanial antigens in liposomes. Neutral and positively charged liposomes were prepared with egg lecithin and cholesterol (7:2 molar ratio) or with egg lecithin, cholesterol, and stearylamine (7:2:2 molar ratio), respectively, as reported earlier (3, 6) . Negatively charged liposomes were prepared with egg lecithin, cholesterol, and phosphatidic acid at a molar ratio of 7:2:2 (5). For encapsulation of the antigens in the vesicles the lipid film was dispersed in PBS containing 2 mg of LAg/ml and sonicated for 30 s in an ultrasonicator. Liposomes with entrapped antigen were separated from the excess free antigen by three successive washing in PBS with ultracentrifugation (105,000 ϫ g, 60 min, 4°C). The amounts of LAg associated per milligram of egg lecithin were 35, 25, and 15 g for positively charged, neutral, and negatively charged liposomes, respectively. Similarly, electroeluted gp63 was entrapped in the positively charged vesicles. The lipid film was dispersed in PBS containing 1 mg of gp63/ml, and 40 g of protein was associated with 1 mg of egg lecithin.
Immunization and challenge infection. BALB/c mice were immunized by three intraperitoneal injections of 20 g of LAg or 10 g of gp63, purified by electroelution and free in PBS or entrapped in liposomes, at 2-week intervals. Animals receiving only PBS or empty liposomes served as controls. Ten days after the last immunization, the immunized and control animals were challenged intravenously with 2.5 ϫ 10 7 freshly transformed L. donovani promastigotes (6). Serum samples collected from each mouse before challenge infection and at 4 months postinfection were stored frozen at Ϫ20°C.
DTH. Delayed-type hypersensitivity (DTH), was determined as an index of cell-mediated immunity. The response was evaluated by measuring the difference between the footpad swelling at 24 h following intradermal inoculation of the test footpad with 50 l of electroeluted gp63 (800 g/ml) and the swelling of the control (PBS-injected) footpad (3) .
Cell proliferation assay. The lymphocyte cultures were obtained from spleens of immunized BALB/c mice. The cells were isolated and counted, and, after evaluation of cell viability by trypan blue exclusion, 2 ϫ 10 5 cells per well were cultured in RPMI 1640 containing 20 mM NaHCO 3 , 10 mM HEPES, 100 U of penicillin per ml, 100 g of streptomycin per ml, 2 mM L-glutamine, and 10% fetal calf serum (complete medium [CM]), with 50 M ␤-mercaptoethanol added.
The cells were cultured in triplicate in a final volume of 200 l/well with eluted antigen (0.7 g/well) at optimum concentrations. The cultures were incubated for 96 h at 37°C in a humidified chamber containing 5% CO 2 In vitro growth of L. donovani in macrophages. Macrophages were collected by peritoneal lavage from immunized BALB/c mice 10 days after the last injection and cultured in CM. A total of Ͼ90% of the cell preparation was identified as macrophages by microscopic observation, and the macrophages were routinely found to be Ͼ98% viable by trypan blue exclusion.
Promastigotes were used to infect cultures of adherent macrophages on glass coverslips (18 mm 2 ; 10 6 macrophages/coverslip) in 0.5 ml of CM at a ratio of 10 parasites/macrophage. After 3 h of incubation, the unphagocytosed parasites were removed by a washing with PBS. Infected macrophages were further incubated in CM at 37°C for 72 h. Cells were fixed in methanol and stained with Giemsa for determination of intracellular parasite numbers.
ELISA. Mice immunized with gp63 or gp63-positively charged liposome and control BALB/c mice were bled 10 days after the last immunization by snipping the tail vein, and the sera were collected. Serum IgG levels were determined by enzyme-linked immunosorbent assay (ELISA) (3). Briefly, 96-well microtiter plates were coated overnight at 4°C with gp63 that had been purified by electroelution (15 g/ml). After being blocked with bovine serum albumin and incubated overnight with serum samples diluted at 1:1,000, the plates were developed by using a 1:5,000 dilution of peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG) antibody (Jackson Immunochemical Research Laboratories).
Mice sera were further assayed for gp63-specific IgG subclass antibodies with a mouse antibody isotyping kit (Sigma Immunochemicals, St. Louis, Mo.). gp63-coated wells, incubated with mice sera as described above, were reacted overnight at 4°C with a 1:2,500 dilution of goat anti-mouse isotype-specific antibodies, followed with a 1:5,000 dilution of peroxidase-conjugated rabbit anti-goat IgG (Jackson Immunochemical Research Laboratories). The plates were developed for color reaction and analyzed by measuring the optical density at 450 nm.
Evaluation of infection. At the times mentioned in Results, the course of infection was monitored by the microscopic examination of Giemsa-stained impression smears of liver and spleen. The parasite load was expressed as Leishman-Donovan units and was calculated by the following formula: number of amastigotes per 1,000 cell nuclei ϫ organ weight (in milligrams) (57) .
SDS-PAGE and Western blot analysis.
Components of the L. donovani promastigote membrane were subjected to SDS-PAGE by the method of Laemmli (32) . Gels were loaded with proteins (amounts are indicated in the figure legends) of the L. donovani ghost membrane; LAg and SLA free in PBS; LAg entrapped in liposomes of neutral, negative, and positive charge; purified gp63 provided by Chang; and gp63 purified by electroelution. Proteins, separated on 10% polyacrylamide, were silver stained (61) .
For Western blot analysis, the resolved proteins were transferred onto nitrocellulose in 25 mM Tris-HCl-192 mM glycine-20% (vol/vol) methanol buffer at 90 V/cm for 90 min (58) . Immunoblot assays were performed according to the method described by Rolland-Burger et al. (49) with slight modifications. The nitrocellulose strips were first saturated and then blocked overnight at room temperature in 100 mM Tris-buffered saline (TBS), pH 7.6, containing 0.1% Tween 20 (T-20) and washed once for 15 min with 0.05% T-20 in TBS (washing buffer) with shaking. Incubation of the nitrocellulose strips with sera from mice immunized with LAg in liposomes, before and after infection, was carried out at 1:500 dilution in the washing buffer for 1 h at room temperature, followed by three washes of 20 min each. gp63, SLA, LAg, and LAg-in-liposome blots were probed with rabbit antisera to purified gp63 at 1:200 dilution, kindly provided by K. P. Chang. The blots were then washed and incubated with peroxidase-conjugated anti-mouse or anti-rabbit (Sigma Immunochemicals) IgG, at a 1:500 dilution in the washing buffer for 1 h at room temperature; this was followed by three washes as described above. The last wash was done without T-20. Enzymatic activity was revealed with 15 mg of 3,3Ј-diaminobenzidine tetrahydrochloride (Sigma Immunochemicals) in 30 ml of TBS containing 15 l of 30% H 2 O 2 . The efficacy of transfer of the leishmanial proteins was regularly checked and confirmed by concurrent gel staining with silver and nitrocellulose membrane staining with 0.1% Ponceau S in 1% acetic acid. The parts of the membrane containing molecular mass standards were marked with ink after the staining with Ponceau S. The specificity of the immune response was assessed by immunoblot analysis employing pooled preimmune sera and only liposome-immunized sera at 1:50 dilution and infected sera at 1:500 dilution in washing buffer.
Statistical analysis. All data comparisons were tested for significance by using Student's t test; P values of Ͻ0.05 were considered significant.
RESULTS

Electrophoretic analysis of the leishmanial antigens and antigens in liposomes.
LAg in association with liposomes induce strong protection against virulent homologous challenge (3, 6). These antigens were extracted from the promastigote ghost membrane (Fig. 1, lane 1 Reactivity of LAg and LAg in liposomes with infected sera is illustrated in Fig. 4 . While there was a dominant 61-to 66-kDa band of LAg with immunized-mouse sera before and after infection ( Fig. 2 and 3) , sera from unimmunized, infected mice exhibited predominantly a 59-kDa band of LAg (Fig. 4, lane 1 Expression of gp63. The dominant band of 61 to 66 kDa for LAg in liposomes as well as SLA exhibited a relative mobility very similar to that of the band for purified gp63 obtained from Chang (Fig. 1) . The specificity of gp63 in blots of LAg, LAg in liposomes, and SLA was confirmed through reactivity with a polyvalent rabbit antiserum raised against this purified protein (Fig. 6 (lanes 3 to 5), and SLA (lane 2) with almost equal intensities and specificities. No bands were present on a similar set of blots probed with normal rabbit serum (data not shown).
Vaccination with gp63 entrapped in liposomes.
To investigate the protective efficacy of gp63 in a liposomal formulation, BALB/c mice were immunized with gp63 purified by electroelution, both free gp63 and gp63 entrapped in positively charged liposomes, prior to challenge with L. donovani promastigotes. The positively charged vesicles were selected because the maximum level of protection against experimental visceral leishmaniasis was observed with these liposomes. After 2 and 4 months of infection mice were sacrificed and parasite loads in their livers and spleens were quantified (Fig. 7 ). Animals immunized with gp63 and gp63 entrapped in liposomes demonstrated significantly enhanced resistance to hepatic infection with L. donovani; the protection induced was 22.8 and 40%, respectively, at 2 months, and 41 and 57%, respectively, at 4 months, compared to the resistance of mice receiving only PBS (P Ͻ 0.01) (Fig. 7A) . The level of protection induced by liposomal gp63 was higher than that with free gp63. However, the difference was not statistically significant. Vaccination with liposomal gp63 could also induce significant protection against parasite growth in the spleen (46% at 2 months and 60% at 4 months; P Ͻ 0.02) (Fig. 7B) . In contrast, free gp63 failed to provide protection in this organ. These results demonstrated the partial but significant vaccine potentiality of gp63 in a liposomal formulation.
Immunization with liposomal gp63 induced the highest level of DTH before, as well as after, challenge infection, correlating with the acquired resistance to infection observed in this group (Fig. 8A) . Free gp63 could also induce DTH responses after immunization. However, after infection the levels of the responses did not differ significantly from those for the controls.
Vaccine-induced stimulation of the cell-mediated immune response was further investigated through the capacity of spleen cells to proliferate in response to concanavalin A and gp63 after immunization. The in vitro responses to the mitogen evaluated 10 days after immunization were found to be strongly proliferative, with no differences between the control and the antigen-immunized groups (data not shown). In the gp63-specific-restimulation assays, cells from mice immunized with liposomal gp63, but not free gp63, proliferated significantly more than controls (P Ͻ 0.05) (Fig. 8B) . A slight proliferative response, however, was also displayed by spleen cells from control mice and mice immunized with gp63 alone when restimulated in vitro. Similar lymphoproliferative responses have been observed earlier for mice immunized with gp63 alone or only adjuvant when stimulated in vitro with gp63 or SLA, respectively (48, 2) . Immunization with gp63, free as well as in a liposome formulation, could also activate peritoneal macrophages to arrest L. donovani amastigote multiplication in vitro (Fig. 8C) . The leishmanicidal activity of macrophages from gp63-liposome immunized mice was, however, significantly higher (P Ͻ 0.002) than that of those from free-gp63-immunized mice. In addition, the percentage of infected macrophages for the liposomal antigen-immunized mice was lower than that for free-antigen-immunized mice (12 versus 53%), demonstrating the enhanced adjuvant activity of the liposomal formulation of gp63. Immunization with gp63 in liposomes induced a strong humoral immune response (Fig. 8D) , which was not observed in free-gp63-immunized or control animals. Th1 and Th2 cells, implicated in differential host response to infectious diseases, promote cellular as well as humoral immune responses. Since antibody isotype profiles provide a convenient surrogate marker for Th1 and Th2 subsets of CD4 ϩ cells (1, 12), we further evaluated the levels of gp63-specific IgG isotype antibodies in serum from the immunized mice (Fig. 8E) . Elicitation of significantly higher levels of IgG2a and IgG2b than of IgG1 (P Ͻ 0.01) points to a Th1-dominated immune response (15) stimulated by gp63 entrapped in liposomes.
DISCUSSION
In our attempt to design a vaccine against visceral leishmaniasis we initiated studies with LAg in association with liposomes as the adjuvant. Entrapment of these antigens in the lipid vesicles conferred significant levels of protection against infection in BALB/c mice. However, the extent of protection showed marked variation for the same antigens depending on whether liposomes were positively charged (3), neutral (6), or negatively charged (5) . The variations may be a result of differential entrapment of the various components of LAg or an adjuvant-induced difference in the immune responses to LAg. Our data indicate that a few immunodominant parasite antigens can elicit strong protective immune responses when used in the context of appropriate adjuvants.
Characterization of the antigens entrapped in liposomes by SDS-PAGE revealed preferential entrapment of a 61-to 66-kDa promastigote antigen by all the liposome preparations. In addition, a number of other proteins of LAg were entrapped within the vesicles. However, all these components were not immunogenic, and their profiles varied with the charge of the associated vesicle. While a few polypeptides, including the dominant 62-to 64-kDa polypeptide, demonstrated seroreactivity in neutral and positively charged liposomes, a larger number were seroreactive in association with negatively charged vesicles, with antisera obtained through the corre- protein antigen conferring protection. The identification of defined parasite proteins and peptides that induce beneficial immune responses may contribute to vaccine development. gp63, the major surface glycoprotein of Leishmania, is highly conserved across species (37) , and its role in induction of protection against murine cutaneous leishmaniasis has been extensively investigated (25, 51, 64) . The subjects of the studies range from the use of the native protein (13, 16, 51) to the use of recombinant gp63 (rgp63) expressed in Salmonella spp. (64) or plasmid pCMV, which encodes gp63 (62) , to the use of T-cell epitopes within gp63 (25, 63) . However, even though L. donovani gp63 has been identified (33) and purified in its native and recombinant forms (43, 52) , its role in protection against infection with L. donovani has not been established. Partial heterologous protection against L. donovani infection in mice by L. major rgp63 expressed in Salmonella was reported (36) . To our knowledge this is the first report of an involvement of L. donovani gp63 in protection against the visceral infection in mice. Even though gp63 was the immundominant antigen of LAg in all the three liposomes, protection conferred by these preparations varied significantly. The choice of adjuvant is important in inducing the correct immune response. In a study undertaken with pure M2 and three different adjuvants, marked variations in the protection against L. mexicana amazonensis conferred by each preparation were observed (11) . It has been shown that cloned T cells with opposite biological effects on murine models of cutaneous leishmaniasis utilize the same or similar T-cell receptors (47) , suggesting that a particular antigen may elicit either a protective or an exacerbating immune response against L. major. L. major antigens drive either a Th1-or Th2-type T-cell response, depending on the local cytokine environment during antigen priming (10, 26, 27, 59) . Antigens of L. donovani, however, did not induce exacerbation. Investigation of the immune responses to the vaccine preparations showed that LAg in neutral liposomes elicited a weak but exclusively Th1-type response after immunization, as characterized by the antibody isotype profile (4). In contrast, the same antigens in positively and negatively charged liposomes induced both Th1-and Th2-type responses. However, while high levels of IgG2a and IgG2b (markers for the induction of a Th1-like response) were simultaneously stimulated, along with IgG1 (Th2-like response), with positively charged liposomes (3), these isotypes were dominated by the levels of IgG1 stimulated by immunization with LAg in negatively charged vesicles (5) . These data indicate that, in contrast to what was found for L. major antigens (55), a concomitant Th2 response with L. donovani antigens does not inhibit the strong Th1 effector function. This conclusion was further substantiated by our investigation of the vaccine potentiality of gp63, purified by electroelution, in association with liposomes. Enhanced protection induced with gp63 in a liposomal formulation corresponded with stronger stimulation of cellular as well as humoral immune responses in comparison with stimulation by gp63 alone. Further analysis of IgG isotypes revealed induction of all the isotypes, suggesting stimulation of both Th1-and Th2-like responses by gp63 in a vaccine formulation. However, stimulation of higher levels of IgG2a and IgG2b antibodies than of IgG1 antibodies indicates the stronger potentiation of a protective Th1 response. The development of a vaccine against L. donovani may, therefore, require that a particular antigen be administered in the context of the right adjuvant for potentiating a dominant Th1 response.
Although gp63 was maximally incorporated in the liposomes, in contrast to the L. major antigens (27) , a greater number of other proteins of L. donovani LAg were also entrapped in the vesicles. However, only a few were immunoreactive with sera from protectively immunized animals and therefore likely to be involved in immunoprotection. While the identity of the 61-to 66-kDa band was confirmed, 72-, 52-, 48-, 45-, 39-, 36-, and 20-kDa antigens of LAg remain unidentified. Screening for parasite antigens on the basis of reactivity with sera from infected susceptible animals has led to the identification of several leishmanial antigens having the ability to confer protective immunity. Some of these well-defined antigens detected through antibody reactivity include LPG (18), gp46/M-2 (11), dp72 (24), PSA-2 (19), P4 and P8 (56), Lcr1 (61) , and LACK (42, 59) . Purified antigens such as L. donovani dp72 and highly conserved polypeptides of Leishmania species such as gp46 and LACK, of 46 and 36 kDa, respectively, may be identified with the immunoreactive components of L. donovani LAg in liposomes and need further testing. In contrast to LAg, SLA, the partially purified antigens from LAg, demonstrated a restricted seroreactivity comparable to that of polypeptides of LAg in positively charged liposomes which exhibited maximum protective activity. Although gp63 is one of the most immunogenic of Leishmania antigens, it is only partially protective against murine visceral leishmaniasis, as observed herein, and against lethal murine cutaneous leishmaniasis, as observed elsewhere (13, 25, 51, 64) . It has been suggested that the efficacy of gp63 could be enhanced, possibly with additional Leishmania antigens (13) . Since SLA is composed of most of the antigens, including gp63, immunogenic in LAg in liposomes and since it induces better protection than gp63 or LAg in liposomes (Rajesh et al., unpublished data), we propose that its components, polypeptides of 72, 52, 48, 45, 41, 39, and 20 kDa, in addition to gp63, be vaccine candidates for future studies of L. donovani antigens in liposomes.
